European Archives - Page 505 of 1233 - European Medical Journal

EMJ Hematology 11.1 2023

We are delighted to present the latest issue of EMJ Hematology! This issue features a review of the scientific highlights from this year’s…

RAS-ERK Pathway Genes Mutations in the Lesions from Various Tumour Loci in Multiple Myeloma

There is a trend towards higher frequency of high-risk cytogenetic aberrations in patients with NRAS gene mutations compared to patients with KRAS gene mutations. Read more.

Untangling Systemic Mastocytosis: An Update on Challenges in the Diagnosis and Treatment of Myeloid Neoplasms with Systemic Mastocytosis

The overarching message from the symposium was that diagnosis of SM-AHN is challenging, and SM is often missed in patients with a myeloid…

Review of the European Association of Allergy and Immunology (EAACI) Congress 2023

This year’s European Association of Allergy and Immunology (EAACI) Hybrid Congress was held in-person, in the beautiful historic…

How Do Human Milk Oligosaccharides Modulate the Immune System in Infants with Cow’s Milk Protein Allergy? Emerging Evidence and Clinical Implications

During this symposium, leading experts in paediatric allergy and immunology examined evidence for the immunomodulatory role of human milk oligosaccharides (HMO) in infants with cow’s milk protein allergy (CMPA), and considered the implications for clinical management.

EMJ Allergy & Immunology 8.1 2023

We are delighted to present the latest issue of EMJ Allergy & Immunology, which includes a review highlighting key sessions from the…

EAACI 2023 Abstract Highlights

The following highlights spotlight selected abstracts presented at the 2023 European Academy of Allergy and Clinical Immunology (EAACI) Congress.

UBA1 Non-M41 Variants Are More Aggressive than UBA1 M41 Variants in Their Haematological Manifestations

The ongoing large-scale screen of non-M41 variants in patients suspected of HMs continues to detect both recurrent and novel non-M41 variants. The patients harbouring non-M41 variants are rare but may be more malignant.

Urticaria and Beyond

Honing in on urticaria and other mast cell driven diseases, experts at the EAACI Congress 2023 presented a forward-thinking session in one of the most insightful symposia from the hybrid meeting hosted in Hamburg, Germany.

Putting Guidelines into Practice: Supporting Young People with Hereditary Angioedema to Live Attack-Free

The availability of specific licensed medicines to treat acute HAE attacks and prophylactic options to prevent future episodes is changing the way people with HAE are treated, and is giving them hope for a future free from debilitating HAE attacks.